Estrogen Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancers Have Similar Oncotype DX Recurrence Score Distribution and Prognosis in African American and Caucasian Patients

被引：0
|
作者：
Logan, Suzanna J. [1 ]
Zhang, Chao [1 ]
Liu, Yuan [1 ]
Siddiqui, Momin T. [1 ]
Cohen, Cynthia [1 ]
Li, Xiaoxian [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
217
引用
收藏
页码：56A / 57A
页数：2
相关论文
共 50 条
  • [1] Estrogen Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancers Have Similar Oncotype DX Recurrence Score Distribution and Prognosis in African American and Caucasian Patients
    Logan, Suzanna J.
    Zhang, Chao
    Liu, Yuan
    Siddiqui, Momin T.
    Cohen, Cynthia
    Li, Xiaoxian
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 56A - 57A
  • [2] Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score
    Meisel, Jane
    Zhang, Chao
    Neely, Cameron
    Menduza, Pia
    You, Shuo
    Han, Tatiana
    Liu, Yuan
    Sahin, Aysegul A.
    O'Regan, Ruth
    Li, Xiaoxian
    [J]. CLINICAL BREAST CANCER, 2018, 18 (05) : 347 - 352
  • [3] Comparison of Oncotype Dx (ODx) 21-gene recurrence score (RS) in African American (AA) and Caucasian (C) patients with hormone receptor-positive (HR+), HER2-negative (HER2-), lymph node-negative (LNN) breast cancer (BC)
    Kabaker, K. B.
    Canar, J.
    Rao, R. D.
    Cobleigh, M. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] The financial burden of using Oncotype Dx for patients with lymph node-negative and estrogen receptor-positive breast cancer in Australia
    Sakata, Shinichiro
    Cronk, Michelle
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (01) : 94 - 95
  • [5] Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer
    Alshamsan, Bader
    Alshibany, Aisha
    Elshenawy, Mahmoud A.
    Badran, Ahmed
    Elhassan, Tusneem
    Ajarim, Dahish
    Alsayed, Adher
    Suleman, Kausar
    Al-Tweigeri, Taher
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 9411 - 9420
  • [6] Discordant classification and outcomes between Prosigna and Oncotype Dx Recurrence Score for ER-positive, HER2-negative, node-negative breast cancer
    Sestak, Ivana
    Ferree, Sean
    Shemesh, Itay
    Buckingham, Wesley
    Cuzick, Jack
    Dowsett, Mitchell
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [7] Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer
    Aline Baltres
    Zeina Al Masry
    Ryad Zemouri
    Severine Valmary-Degano
    Laurent Arnould
    Noureddine Zerhouni
    Christine Devalland
    [J]. Breast Cancer, 2020, 27 : 1007 - 1016
  • [8] Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer
    Baltres, Aline
    Al Masry, Zeina
    Zemouri, Ryad
    Valmary-Degano, Severine
    Arnould, Laurent
    Zerhouni, Noureddine
    Devalland, Christine
    [J]. BREAST CANCER, 2020, 27 (05) : 1007 - 1016
  • [9] Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer
    Rakha, Emad A.
    Agarwal, Devika
    Green, Andrew R.
    Ashankyty, Ibraheem
    Ellis, Ian O.
    Ball, Graham
    Alaskandarany, Mohammed A.
    [J]. HISTOPATHOLOGY, 2017, 70 (04) : 622 - 631
  • [10] Routine Use of Oncotype DX Recurrence Score Testing in Node-Positive Hormone Receptor-Positive HER2-Negative Breast Cancer: The Time Has Come
    Mittendorf, Elizabeth A.
    King, Tari A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (05) : 1173 - 1175
12345